Elio Gregory Pizzutilo

Cited by

	All	Since 2019
Citations	905	903
h-index	12	12
i10-index	13	13

280

140

210

2019202020212022202320249 75 204 245 266 100

Public access

View all

5 articles

2 articles

available

not available

Based on funding mandates

Co-authors

Salvatore SienaUniversità degli Studi di Milano, Dipartimento di Oncologia, Ospedale Niguarda, Milano, ItalyVerified email at unimi.it
Andrea Sartore-BianchiClinical Molecular Oncology, Niguarda Cancer Center, Milano - ItalyVerified email at ospedaleniguarda.it
Alessio AmatuNiguarda Cancer Center, Grande Ospedale Metropolitano Niguarda, Milan, ItalyVerified email at ospedaleniguarda.it
giulio cereaNiguarda Cancer Center, ASST Grande Ospedale Metropolitano Niguarda, Milan, ItalyVerified email at ospedaleniguarda.it
Laura GiannettaNiguarda Cancer Center, Ospedale Niguarda Ca' Granda, Milan, ItalyVerified email at ospedaleniguarda.it
Francesco Scaglioneuniversità di MilanoVerified email at unimi.it
Gianluca MauriUniversità degli Studi di MilanoVerified email at unimi.it
Gianluca TomaselloASST Ospedale Maggiore di CremaVerified email at asst-crema.it
Silvia MarsoniIFOMVerified email at ifom.eu
Laura PalmeriNiguarda Cancer Center, Grande Ospedale Metropolitano Niguarda, Milan, ItalyVerified email at ospedaleniguarda.it
Marina Chiara GarassinoThe University of ChicagoVerified email at medicine.bsd.uchicago.edu
MICHELE GHIDINIMedical Oncologist, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, ItalyVerified email at policlinico.mi.it
Federica Di NicolantonioUniversity of Torino, Dept of Oncology & Candiolo Cancer Institute, FPO - IRCCSVerified email at unito.it
GIULIA SIRAVEGNAInstructor in Medicine, Harvard Medical SchoolVerified email at mgh.harvard.edu
Angelo VanzulliOspedale Niguarda, University of Milan, ItalyVerified email at ospedaleniguarda.it
Giovanna MarrapeseNiguarda Cancer Center, Ospedale Niguarda Ca' Granda, Milan, ItalyVerified email at ospedaleniguarda.it
Stefano StabileASST Grande Ospedale Metropolitano NiguardaVerified email at ospedaleniguarda.it
Fotios LoupakisIstituto Oncologico Veneto, Padua ITALYVerified email at iov.veneto.it
Antonio MarraMemorial Sloan Kettering Cancer CenterVerified email at mskcc.org
Massimo TorreThoracic surgical department Niguarda Hospital Milano ItalyVerified email at ospedaleniguarda.it

Elio Gregory Pizzutilo

Università degli Studi di Milano, Niguarda Cancer Center, Grande Ospedale Metropolitano Niguarda

Verified email at ospedaleniguarda.it

Medical Oncology


Title Sort by citations Sort by year Sort by title	Cited by Cited by	Year
Association of steroids use with survival in patients treated with immune checkpoint inhibitors: a systematic review and meta-analysis F Petrelli, D Signorelli, M Ghidini, A Ghidini, EG Pizzutilo, L Ruggieri, ... Cancers 12 (3), 546, 2020	215	2020
Tropomyosin receptor kinase (TRK) biology and the role of NTRK gene fusions in cancer A Amatu, A Sartore-Bianchi, K Bencardino, EG Pizzutilo, F Tosi, S Siena Annals of Oncology 30, viii5-viii15, 2019	215	2019
First-line pembrolizumab in advanced non–small cell lung cancer patients with poor performance status F Facchinetti, G Mazzaschi, F Barbieri, F Passiglia, F Mazzoni, R Berardi, ... European Journal of Cancer 130, 155-167, 2020	111	2020
Retreatment with anti-EGFR monoclonal antibodies in metastatic colorectal cancer: Systematic review of different strategies G Mauri, EG Pizzutilo, A Amatu, K Bencardino, L Palmeri, EF Bonazzina, ... Cancer treatment reviews 73, 41-53, 2019	85	2019
Evaluation of COVID-19 impact on DELAYing diagnostic-therapeutic pathways of lung cancer patients in Italy (COVID-DELAY study): fewer cases and higher stages from a real-world … L Cantini, G Mentrasti, GL Russo, D Signorelli, G Pasello, E Rijavec, ... ESMO open 7 (2), 100406, 2022	47	2022
Liquid biopsy for rectal cancer: A systematic review D Massihnia, EG Pizzutilo, A Amatu, F Tosi, S Ghezzi, K Bencardino, ... Cancer treatment reviews 79, 101893, 2019	34	2019
High circulating methylated DNA is a negative predictive and prognostic marker in metastatic colorectal cancer patients treated with regorafenib A Amatu, M Schirripa, F Tosi, S Lonardi, K Bencardino, E Bonazzina, ... Frontiers in oncology 9, 622, 2019	34	2019
Entrectinib for the treatment of metastatic NSCLC: safety and efficacy A Sartore-Bianchi, EG Pizzutilo, G Marrapese, F Tosi, G Cerea, S Siena Expert Review of Anticancer Therapy 20 (5), 333-341, 2020	31	2020
Efficacy and safety of anti-PD-1 immunotherapy in patients aged≥ 75 years with non–small-cell lung cancer (NSCLC): an Italian, multicenter, retrospective study A Luciani, A Marra, L Toschi, D Cortinovis, S Fava, V Filipazzi, A Tuzi, ... Clinical Lung Cancer 21 (6), e567-e571, 2020	26	2020
Pneumatosis intestinalis induced by anticancer treatment: a systematic review G Gazzaniga, F Villa, F Tosi, EG Pizzutilo, S Colla, S D’Onghia, ... Cancers 14 (7), 1666, 2022	21	2022
Liquid biopsy for small cell lung cancer either de novo or transformed: systematic review of different applications and meta-analysis EG Pizzutilo, M Pedrani, A Amatu, L Ruggieri, C Lauricella, SM Veronese, ... Cancers 13 (9), 2265, 2021	15	2021
Chemotherapy in non-small cell lung cancer patients after prior immunotherapy: the multicenter retrospective CLARITY study M Bersanelli, S Buti, D Giannarelli, A Leonetti, A Cortellini, GL Russo, ... Lung Cancer 150, 123-131, 2020	15	2020
Immune checkpoint inhibitors for unresectable malignant pleural mesothelioma G Metro, D Signorelli, EG Pizzutilo, L Giannetta, G Cerea, M Garaffa, ... Human Vaccines & Immunotherapeutics 17 (9), 2972-2980, 2021	12	2021
The predictive role of ERBB2 point mutations in metastatic colorectal cancer: A systematic review C Vaghi, G Mauri, AG Agostara, G Patelli, EG Pizzutilo, Y Nakamura, ... Cancer Treatment Reviews 112, 102488, 2023	8	2023
Erratum to ‘Evaluation of COVID-19 impact on DELAYing diagnostic-therapeutic pathways of lung cancer patients in Italy (COVID-DELAY study): fewer cases and higher stages from a … L Cantini, G Mentrasti, GL Russo, D Signorelli, G Pasello, E Rijavec, ... ESMO open 7 (2), 2022	7	2022
Application of histology-agnostic treatments in metastatic colorectal cancer A Sartore-Bianchi, AG Agostara, G Patelli, G Mauri, EG Pizzutilo, S Siena Digestive and Liver Disease 54 (10), 1291-1303, 2022	6	2022
996P Activity of OsimeRTInib in NSCLC with UNcommon EGFR Mutations: Retrospective observational multicenter study (ARTICUNO) EG Pizzutilo, G Cerea, S Oresti, AG Agostara, D Signorelli, S Stabile, ... Annals of Oncology 33, S1009, 2022	5	2022
A systematic review and meta-analysis on the optimal treatment duration of checkpoint inhibitoRS in solid tumors: The OTHERS study G Bogani, M Cinquini, D Signorelli, EG Pizzutilo, R Romanò, M Bersanelli, ... Critical Reviews in Oncology/Hematology 187, 104016, 2023	4	2023
Moving immune checkpoint inhibitors to early non-small cell lung cancer: a narrative review G Viscardi, F Vitiello, A Servetto, V Gristina, EG Pizzutilo, MA Canciello, ... Cancers 14 (23), 5810, 2022	3	2022
Concurrent small cell transformation and emergence of trans-C797S and T790M mutations under sequential treatment with EGFR inhibitors in lung adenocarcinoma EG Pizzutilo, C Lauricella, G Cerea, L Giannetta, G Tomasello, S Stabile, ... JCO Precision Oncology 2020, 2020	3	2020

The system can't perform the operation now. Try again later.

Articles 1–20

Citations per year

Duplicate citations

Merged citations

Add co-authorsCo-authors

Follow

Cited by

Co-authors